Quotables
"We are probably nearing the limit of all we can know about astronomy."
Simon Newcomb, astronomer ; 1888
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120295900 | 1,3-OXAZINES AS BACE 1 AND/OR BACE2 INHIBITORS The present invention provides compounds of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active subs... | 11/22/2012 |
| 20120258962 | 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS The present invention provides 4-(3-Amino-phenyl)-5,6-dihydro-4H-[1,3]oxazin-2-ylamines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing th... | 10/11/2012 |
| 20120245157 | OXAZINE DERIVATIVES The present invention provides, for example, a compound mentioned below as a medicament for treating or preventing the diseases induced by production, secretion or deposition of amyloid-β proteins. A compound of the formula (I): | 09/27/2012 |
| 20120165521 | LOW-VOC POLYAMINO ALCOHOLS A method for producing a polyamino-polyalcohol. The method comprises steps of: (a) combining an aminoalcohol of formula (I) with a nitro-diol of formula (II) | 06/28/2012 |
| 20110165101 | PHOTO-LABILE PRO-FRAGRANCE CONJUGATES The present invention relates to photo-labile pro-fragrance conjugates comprising:
| 07/07/2011 |
| 20110144097 | 2-AMINO-5,5-DIFLUORO-5,6-DIHYDRO-4H-[1,3]OXAZIN-4-YL)-PHENYL]-AMIDES The present invention relates to 2-Amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amides of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions... | 06/16/2011 |
| 20110028367 | PHOTO-LABILE PRO-FRAGRANCE CONJUGATES The present invention relates to photo-labile pro-fragrance conjugates comprising:
| 02/03/2011 |
| 20100256114 | Amido Compounds And Their Use As Pharmaceuticals The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases ass... | 10/07/2010 |
| 20100048545 | Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity The invention relates to 4-hydroxyisoleucine, isomers, analogs, lactones, salts, and prodrugs thereof, to processes for their preparation, and to pharmaceutical compositions comprising the same. More particularly, the invention relates to the use of those compounds in t... | 02/25/2010 |
| 20090281309 | METHOD FOR PRODUCING 2-OXAZOLINE ANALOGUE OR 1,3-OXAZINE ANALOGUE The present invention is a method for producing a 2-oxazoline analogue or a 1,3-oxazine analogue represented by the following general formula (3) by reacting a 1,2-aminoalcohol compound or a 1,2-aminothiol compound with an α,α-dihaloamine compound. | 11/12/2009 |
| 20090104116 | COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF The present invention is related to a compound of formula (I), wherein A is a nonaromatic heterocyclic ring, Ar is either absent or phenylene; Ψ is a radical of formula (II), R2 is a hydrophobic moiety; and G is a radical containing one or more moieties sel... | 04/23/2009 |
| 20090069533 | Benzoxazine monomers, polymers and compositions Benzoxazine monomers comprising at least one pendant group are described. (Co)Polymers comprising at least one benzoxazine monomer having at least one pendant group are also described. In a preferred embodiment, the pendant group is located in a side chain of the benzox... | 03/12/2009 |
| 20080318905 | Prodrugs and methods of making and using the same Prodrugs of parent drugs and methods of making and using the same are described. The prodrugs comprise an amine-containing parent drug moiety and a prodrug moiety, such as methoxyphosphonic acid or ethoxyphosphonic acid. The prodrugs may be employed in therapy for the t... | 12/25/2008 |
| 20080171681 | Photo-labile pro-fragrance conjugates The present invention relates to photo-labile pro-fragrance conjugates comprising:
| 07/17/2008 |
| 20080146797 | PROCESS FOR SYNTHESIZING HETEROCYCLIC COMPOUNDS The invention provides the process illustrated in scheme 1 for synthesizing heterocyclic compounds of formula I. In the process, an isothiocyanate of formula II is initially reacted with a primary amine or fo... | 06/19/2008 |
| 20080027211 | Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments Enantiopure heterocyclic compound Enantiopure heterocyclic compound of formula (I) in which J is chosen from C, N, O and S; Z is H or a group for protecting the amino functional group, R3 denotes H or an organic residue, m is 0, 1 or 2 and n is 0, 1 or 2, and... | 01/31/2008 |
| 20070281930 | Novel Insecticides Compounds of the formula in which
| |
| 20070264217 | Photo-labile pro-fragrance conjugates The present invention relates to photo-labile pro-fragrance conjugates comprising: a) a photo-labile unit which upon exposure to electromagnetic radiation is capable of releasing a pro-fragrance unit; and b) a pro-fragrance unit, which when so released is either i) a pr... | 11/15/2007 |
| 20070208014 | NOVEL 2-SUBSTITUTED BENZIMIDAZOLES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. ... | 09/06/2007 |
| 20070082895 | Novel mycobacterial inhibitors The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or the general formula (Ib) salts, quaternary amines, stereochemically isomeric forms, tautomeric forms and N-oxide forms thereof, wherein R1 04/12/2007 | |
| 20050227969 | EP4 receptor agonist, compositions and methods thereof This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a pati... | 10/13/2005 |
| 20050119260 | Inhibitors of cellular necrosis The present invention relates to compounds and pharmaceutical preparations and their use in therapy for preventing or treating trauma, ischemia, stroke and degenerative diseases associated with cell death. Methods and compositions of the invention are particularly usefu... | 06/02/2005 |
| 20050020505 | R-isomer of beta amino acid compounds as integrin receptor antagonists derivatives The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the α 01/27/2005 | |
